Menopause and Bone Health: What to Know About Osteoporosis Risk

MARKABLE Research Team · May 2026 · 7 min read

Bone health is one of those topics that rarely feels urgent until something breaks. But for women going through menopause, the changes happening inside your bones are significant, silent, and time-sensitive. The years surrounding menopause represent the period of most rapid bone loss in a woman's life.

Understanding what's happening, why, and what you can do about it gives you the chance to act before a fracture delivers the diagnosis.

Why menopause accelerates bone loss

Your bones are living tissue, constantly being broken down and rebuilt. Two types of cells manage this process: osteoclasts (which break down old bone) and osteoblasts (which build new bone). In younger women, oestrogen helps keep these two processes in balance by restraining osteoclast activity.

When oestrogen levels drop during menopause, osteoclasts become more active. Bone is broken down faster than it can be rebuilt. The result is a net loss of bone density that is particularly steep during the first 5 to 7 years after menopause.

20%

of bone density can be lost in the 5-7 years following menopause

Source: Royal Osteoporosis Society

This rate of loss is not uniform. Trabecular bone (the spongy interior of bones, found in the spine and wrist) is affected earlier and more dramatically than cortical bone (the dense outer shell). This is why vertebral compression fractures are often the first clinical sign of osteoporosis.

Osteoporosis: the silent condition

Osteoporosis is often called a "silent disease" because bone loss itself produces no symptoms. You cannot feel your bones becoming weaker. There is no pain signal, no warning indicator. The first sign is frequently a fracture, sometimes from an impact that would not have caused a break in younger years: a stumble, a minor fall, even lifting something heavy.

The most common osteoporotic fractures occur in the hip, spine, and wrist. Of these, hip fractures carry the most serious consequences. In the UK, there are approximately 76,000 hip fractures per year, and in older adults, hip fractures are associated with significant loss of independence and increased mortality risk.

Risk factors beyond menopause

While all postmenopausal women face increased bone loss, some women are at substantially higher risk. Understanding these risk factors can help you and your GP assess whether early screening or intervention is warranted.

Non-modifiable risk factors

Modifiable risk factors

Note on testosterone and bone: Testosterone also contributes to bone density. Women produce small amounts of testosterone, and levels decline with age. This is another hormonal factor in postmenopausal bone loss that is increasingly recognised in clinical research.

When and how to get tested

The gold standard for measuring bone density is DEXA (dual-energy X-ray absorptiometry). It's a quick, painless scan that measures bone mineral density at the hip and spine. The results are reported as a T-score:

In the UK, NICE recommends using the FRAX fracture risk assessment tool for postmenopausal women with risk factors. Your GP can calculate your FRAX score, and if it indicates elevated risk, refer you for a DEXA scan through the NHS. Many experts argue that baseline screening at the time of menopause would allow for earlier intervention and better long-term outcomes.

If you have any of the risk factors listed above, consider asking your GP about screening. The information from a baseline scan can guide decisions about prevention strategies.

What protects your bones: the evidence

Calcium

The recommended daily calcium intake for postmenopausal women is 700 mg per day (NHS recommendation), though many experts suggest 1,000-1,200 mg. Dietary sources are preferred over supplements when possible. Dairy products, leafy greens (kale, broccoli, bok choy), sardines, and fortified foods are all good sources.

If you use calcium supplements, it is generally recommended to take them in divided doses (no more than 500-600 mg at a time) for better absorption. Calcium citrate is absorbed with or without food, while calcium carbonate requires stomach acid and should be taken with meals.

Vitamin D

Vitamin D is essential for calcium absorption. Without adequate vitamin D, your body cannot effectively use the calcium you consume. Many postmenopausal women are vitamin D deficient, particularly in the UK where sunlight exposure is limited for much of the year.

The NHS recommends 10 micrograms (400 IU) of vitamin D daily for all adults during autumn and winter, but many clinicians recommend 1,000-2,000 IU year-round for women at risk of osteoporosis. A blood test for 25-hydroxyvitamin D can determine whether your levels are adequate.

Weight-bearing exercise

Exercise is one of the most effective tools for maintaining bone density. But not all exercise is equal for bone health. Weight-bearing and resistance exercises are what stimulate bone formation:

Swimming and cycling, while excellent for cardiovascular health, are not weight-bearing and have less impact on bone density.

Understanding your hormonal wellness

MARKABLE tracks hormonal wellness patterns that may affect multiple systems, including bone health. Your first check is free.

Start My Free Check →

Hormone therapy

Oestrogen therapy is one of the most effective treatments for preventing postmenopausal bone loss. Studies have consistently shown that hormone therapy reduces the risk of hip and vertebral fractures. The Women's Health Initiative (WHI) trial found that oestrogen plus progestin therapy reduced hip fractures by 34%.

Hormone therapy is generally most appropriate for women who are within 10 years of menopause onset or under age 60, and who also have other menopausal symptoms (hot flushes, sleep disruption) that would benefit from treatment. NICE guidelines support the use of HRT for symptom management, with bone protection as an additional benefit. The decision should be made in consultation with your GP, weighing the benefits against individual risk factors.

Medications for osteoporosis

For women who are diagnosed with osteoporosis or who have high fracture risk, several medication classes are available on the NHS:

The importance of fall prevention

Preventing fractures is not only about bone strength. It is also about not falling. For postmenopausal women, fall prevention strategies become increasingly important with age:

Building a bone health plan

Bone health is not something you can address with a single intervention. The most effective approach combines multiple strategies:

  1. Know your baseline. Ask your GP about a DEXA scan if you have risk factors. Understand where you stand.
  2. Optimise nutrition. Ensure adequate calcium (at least 700 mg/day, ideally 1,000-1,200 mg) and vitamin D (at least 400 IU/day, potentially more). Get levels tested.
  3. Move your body. Prioritise weight-bearing and resistance exercise at least 3-4 times per week.
  4. Address hormonal health. If you are experiencing menopausal symptoms, discuss with your GP whether hormone therapy might serve dual purposes.
  5. Avoid bone-depleting habits. Quit smoking, moderate alcohol intake, and review medications that may affect bone.
  6. Monitor over time. If you have osteopenia or osteoporosis, regular DEXA scans (typically every 2 years) can track your progress.

The bottom line

Menopause-related bone loss is significant, but it is not inevitable destiny. The years around menopause are a critical window for intervention. Understanding your risk, getting appropriate screening, and taking evidence-based preventive steps can dramatically reduce your fracture risk in the decades ahead.

The key is acting before a fracture forces the conversation. Your bones cannot tell you they are weakening, but the data can.

This article is for informational purposes only and does not constitute medical advice. MARKABLE is a general wellness product for personal awareness and self-monitoring. It is not a medical device and is not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare clinician for medical guidance.